ARANESP (DARBEPOETIN ALFA IN POLYSORBATE 80)

10 mcg/0.4 mL (in polysorbate) injection syringe

• Dosage information is not available

100 mcg/0.5 mL (in polysorbate) injection syringe

• Dosage information is not available

150 mcg/0.3 mL (in polysorbate) injection syringe

• Dosage information is not available

200 mcg/0.4 mL (in polysorbate) injection syringe

• Dosage information is not available

25 mcg/0.42 mL (in polysorbate) injection syringe

• Dosage information is not available

300 mcg/0.6 mL (in polysorbate) injection syringe

• Dosage information is not available

40 mcg/0.4 mL (in polysorbate) injection syringe

• Dosage information is not available

500 mcg/mL (in polysorbate) injection syringe

• Inject 1 milliliter (500 mcg) by subcutaneous route every 3 weeks in the abdomen, thigh, upper buttocks, or outer upper arm (rotate site)

60 mcg/0.3 mL (in polysorbate) injection syringe

• Dosage information is not available

100 mcg/mL (in polysorbate) Injection

• Dosage information is not available

150 mcg/0.75 mL (in polysorbate) Injection

• Dosage information is not available

200 mcg/mL (in polysorbate) Injection

• Dosage information is not available

25 mcg/mL (in polysorbate) Injection

• Dosage information is not available

300 mcg/mL (in polysorbate) Injection

• Dosage information is not available

40 mcg/mL (in polysorbate) Injection

• Dosage information is not available

60 mcg/mL (in polysorbate) Injection

• Dosage information is not available

Anemia due to chemotherapy and radiotherapy combination

• Inject 2.25 mcg/kg by subcutaneous route once weekly in the abdomen, thighs, upper outer areas of buttocks, or outer area of upper arms rotating injection sites

• Inject 500 mcg by subcutaneous route every 3 weeks in the abdomen, thighs, upper outer areas of buttocks, or outer area of upper arms rotating injection sites

• Inject 2.25 mcg/kg by subcutaneous route once weekly

• Inject 500 mcg by subcutaneous route every 3 weeks

• Inject 1 milliliter (500 mcg) by subcutaneous route every 3 weeks in the abdomen, thighs, upper outer areas of buttocks, or outer area of upper arms rotating injection sites

• Inject 1 milliliter (500 mcg) by subcutaneous route every 3 weeks in the abdomen, thigh, upper buttocks, or outer upper arm (rotate site)

Anemia in chronic kidney disease

• Inject 0.45 mcg/kg by intravenous route every 4 weeks

• Inject 0.45 mcg/kg by subcutaneous route every 4 weeks in the abdomen, thighs, upper outer areas of buttocks, or outer area of upper arms rotating injection sites

• Inject 0.45 mcg/kg by subcutaneous route once weekly in the abdomen, thighs, upper outer areas of buttocks, or outer area of upper arms rotating injection sites

• Infuse 0.45 mcg/kg by intravenous route once weekly

• Inject 0.75 mcg/kg by intravenous route every 2 weeks

• Inject 0.75 mcg/kg by subcutaneous route every 2 weeks in the abdomen, thighs, upper outer areas of buttocks, or outer area of upper arms rotating injection sites

• Inject 1 milliliter (140 mg) by subcutaneous route every 2 weeks in the abdomen, thigh, or outer area of upper arm (rotate sites)

Chemotherapy-induced anemia

• Inject 2.25 mcg/kg by subcutaneous route once weekly in the abdomen, thighs, upper outer areas of buttocks, or outer area of upper arms rotating injection sites

• Inject 500 mcg by subcutaneous route every 3 weeks in the abdomen, thighs, upper outer areas of buttocks, or outer area of upper arms rotating injection sites

• Inject 2.25 mcg/kg by subcutaneous route once weekly

• Inject 500 mcg by subcutaneous route every 3 weeks

• Inject 1 milliliter (500 mcg) by subcutaneous route every 3 weeks in the abdomen, thighs, upper outer areas of buttocks, or outer area of upper arms rotating injection sites

• Inject 1 milliliter (500 mcg) by subcutaneous route every 3 weeks in the abdomen, thigh, upper buttocks, or outer upper arm (rotate site)